BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Thursday reported a loss of $20 million in its third quarter.

The Brisbane, California-based company said it had a loss of 54 cents per share. Losses, adjusted for non-recurring costs and stock option expense, were 1 cent per share.

The molecular diagnostics company posted revenue of $21.2 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $18.5 million.

CareDx expects full-year earnings in the range of $74 to $75 per share.

CareDx shares have more than tripled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $27.74, climbing fivefold in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CDNA at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.